• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮与肾小球滤过——在普通人群中的观察。

Aldosterone and glomerular filtration--observations in the general population.

机构信息

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.

出版信息

BMC Nephrol. 2014 Mar 10;15:44. doi: 10.1186/1471-2369-15-44.

DOI:10.1186/1471-2369-15-44
PMID:24612948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3975288/
Abstract

BACKGROUND

Increasing evidence suggests that aldosterone promotes renal damage. Since data on the association between aldosterone and renal function in the general population are sparse, we chose to address this issue. We investigated the associations between the plasma aldosterone concentration (PAC) or the aldosterone-to-renin ratio (ARR) and the estimated glomerular filtration rate (eGFR) in a sample of adult men and women from Northeast Germany.

METHODS

A study population of 1921 adult men and women who participated in the first follow-up of the Study of Health in Pomerania was selected. None of the subjects used drugs that alter PAC or ARR. The eGFR was calculated according to the four-variable Modification of Diet in Renal Disease formula. Chronic kidney disease (CKD) was defined as an eGFR < 60 ml/min/1.73 m2.

RESULTS

Linear regression models, adjusted for sex, age, waist circumference, diabetes mellitus, smoking status, systolic and diastolic blood pressures, serum triglyceride concentrations and time of blood sampling revealed inverse associations of PAC or ARR with eGFR (ß-coefficient for log-transformed PAC -3.12, p < 0.001; ß-coefficient for log-transformed ARR -3.36, p < 0.001). Logistic regression models revealed increased odds for CKD with increasing PAC (odds ratio for a one standard deviation increase in PAC: 1.35, 95% confidence interval: 1.06-1.71). There was no statistically significant association between ARR and CKD.

CONCLUSION

Our study demonstrates that PAC and ARR are inversely associated with the glomerular filtration rate in the general population.

摘要

背景

越来越多的证据表明醛固酮可促进肾脏损伤。由于人群中醛固酮与肾功能之间关系的数据较少,因此我们选择解决这个问题。我们研究了德国东北部成年男性和女性样本中血浆醛固酮浓度(PAC)或醛固酮与肾素比值(ARR)与估算肾小球滤过率(eGFR)之间的关系。

方法

选择了参加波美拉尼亚健康研究第一次随访的 1921 名成年男性和女性作为研究人群。研究对象均未使用改变 PAC 或 ARR 的药物。根据四变量肾脏病饮食改良公式计算 eGFR。慢性肾脏病(CKD)定义为 eGFR < 60 ml/min/1.73 m2。

结果

调整性别、年龄、腰围、糖尿病、吸烟状况、收缩压和舒张压、血清甘油三酯浓度和采血时间后,线性回归模型显示 PAC 或 ARR 与 eGFR 呈负相关(log 转换后的 PAC 的回归系数为-3.12,p < 0.001;log 转换后的 ARR 的回归系数为-3.36,p < 0.001)。Logistic 回归模型显示,PAC 升高与 CKD 的发生几率增加相关(PAC 增加一个标准差的优势比:1.35,95%置信区间:1.06-1.71)。ARR 与 CKD 之间无统计学显著相关性。

结论

我们的研究表明,PAC 和 ARR 与普通人群的肾小球滤过率呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f7/3975288/06331f6466fe/1471-2369-15-44-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f7/3975288/06331f6466fe/1471-2369-15-44-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f7/3975288/06331f6466fe/1471-2369-15-44-1.jpg

相似文献

1
Aldosterone and glomerular filtration--observations in the general population.醛固酮与肾小球滤过——在普通人群中的观察。
BMC Nephrol. 2014 Mar 10;15:44. doi: 10.1186/1471-2369-15-44.
2
A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population.高醛固酮与肾素比值与一般人群中高血清甲状旁腺激素浓度有关。
J Clin Endocrinol Metab. 2014 Mar;99(3):965-71. doi: 10.1210/jc.2013-3214. Epub 2013 Jan 1.
3
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.血浆肾素活性和醛固酮与肾素比值与慢性肾脏病的发生有关:大盐原研究。
J Hypertens. 2012 Aug;30(8):1632-8. doi: 10.1097/HJH.0b013e328354f65b.
4
Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects.血浆醛固酮水平和醛固酮与肾素比值与年轻至中年受试者的血管内皮功能障碍有关。
Atherosclerosis. 2011 Dec;219(2):875-9. doi: 10.1016/j.atherosclerosis.2011.09.008. Epub 2011 Sep 16.
5
Aldosterone renin ratio and chronic kidney disease.醛固酮肾素比值与慢性肾脏病
Saudi J Kidney Dis Transpl. 2020 Jan-Feb;31(1):70-78. doi: 10.4103/1319-2442.279963.
6
Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort.血浆肾素活性和醛固酮-肾素比值与慢性肾脏病患病率的关系:凯撒永久南加州队列研究。
J Hypertens. 2011 Nov;29(11):2226-35. doi: 10.1097/HJH.0b013e32834bbc8a.
7
Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).基于人群的波罗的海健康研究(SHIP-1)中醛固酮、肾素和醛固酮与肾素比值的参考区间。
Horm Metab Res. 2010 Jun;42(6):392-9. doi: 10.1055/s-0030-1247545. Epub 2010 Feb 15.
8
Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia.肥胖对活性肾素与血浆醛固酮浓度以及醛固酮与肾素比值和子痫前期之间关联的影响。
Pregnancy Hypertens. 2018 Oct;14:139-144. doi: 10.1016/j.preghy.2018.09.007. Epub 2018 Sep 27.
9
Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.醛固酮和肾素浓度与炎症的关联——波美拉尼亚健康研究及德国原发性醛固酮增多症登记研究
Endocrine. 2017 Aug;57(2):298-307. doi: 10.1007/s12020-017-1348-8. Epub 2017 Jun 22.
10
Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.醛固酮与肾素比值与2型糖尿病患者的糖尿病肾病相关:一项单中心回顾性研究
Med Sci Monit. 2022 Mar 20;28:e935615. doi: 10.12659/MSM.935615.

引用本文的文献

1
Risk factors for renal impairment in primary aldosteronism: a retrospective study.原发性醛固酮增多症患者肾功能损害的危险因素:一项回顾性研究。
Front Endocrinol (Lausanne). 2025 Aug 11;16:1606182. doi: 10.3389/fendo.2025.1606182. eCollection 2025.
2
Aldosterone's impact on kidney health: exploring the benefits of mineralocorticoid receptor antagonists for renal protection.醛固酮对肾脏健康的影响:探索盐皮质激素受体拮抗剂对肾脏保护的益处。
Am J Transl Res. 2024 Aug 15;16(8):4246-4255. doi: 10.62347/NRGG6465. eCollection 2024.
3
Adverse Effects of Aldosterone: Beyond Blood Pressure.

本文引用的文献

1
Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases.醛固酮受体拮抗剂在蛋白尿性肾脏疾病患者中的肾脏保护作用。
Nephrol Dial Transplant. 2013 Feb;28(2):405-12. doi: 10.1093/ndt/gfs429. Epub 2012 Dec 4.
2
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era.醛固酮受体拮抗剂与原发性醛固酮增多症的肾脏损害:新时代的开启。
Eur J Endocrinol. 2012 Dec 10;168(1):C1-5. doi: 10.1530/EJE-12-0899. Print 2013 Jan.
3
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
醛固酮的不良反应:不仅仅是血压。
J Am Heart Assoc. 2024 Apr 2;13(7):e030142. doi: 10.1161/JAHA.123.030142. Epub 2024 Mar 18.
4
The role of aldosterone and ideal cardiovascular health in incident diabetes: The Jackson Heart Study.醛固酮与理想心血管健康在新发糖尿病中的作用:杰克逊心脏研究
Am J Prev Cardiol. 2023 Jan 15;13:100466. doi: 10.1016/j.ajpc.2023.100466. eCollection 2023 Mar.
5
Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease.醛固酮受体在血管细胞中出现的新作用:对理解心血管疾病中性别差异的意义。
Am J Physiol Cell Physiol. 2023 Jan 1;324(1):C193-C204. doi: 10.1152/ajpcell.00372.2022. Epub 2022 Nov 28.
6
Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.接受肾素-血管紧张素系统抑制剂治疗蛋白尿性慢性肾病的犬中醛固酮突破的流行率。
J Vet Intern Med. 2022 Nov;36(6):2088-2097. doi: 10.1111/jvim.16573. Epub 2022 Nov 9.
7
Aldosterone in chronic kidney disease and renal outcomes.醛固酮在慢性肾脏病及肾脏结局中的作用。
Eur Heart J. 2022 Oct 11;43(38):3781-3791. doi: 10.1093/eurheartj/ehac352.
8
Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.醛固酮与肾素比值与2型糖尿病患者的糖尿病肾病相关:一项单中心回顾性研究
Med Sci Monit. 2022 Mar 20;28:e935615. doi: 10.12659/MSM.935615.
9
Is acute kidney injury after laparoscopic adrenalectomy related to the progression of chronic kidney disease in patients with primary aldosteronism?腹腔镜肾上腺切除术术后急性肾损伤是否与原发性醛固酮增多症患者慢性肾脏病的进展有关?
Investig Clin Urol. 2021 Sep;62(5):560-568. doi: 10.4111/icu.20200582. Epub 2021 Jul 22.
10
Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.影响健康犬和自然发生黏液瘤样二尖瓣疾病犬尿醛固酮与肌酐比值的因素。
BMC Vet Res. 2021 Jan 7;17(1):15. doi: 10.1186/s12917-020-02716-6.
醛固酮增多症中依普利酮或螺内酯治疗对保护肾功能的疗效。
Eur J Endocrinol. 2012 Dec 10;168(1):75-81. doi: 10.1530/EJE-12-0631. Print 2013 Jan.
4
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.血浆肾素活性和醛固酮与肾素比值与慢性肾脏病的发生有关:大盐原研究。
J Hypertens. 2012 Aug;30(8):1632-8. doi: 10.1097/HJH.0b013e328354f65b.
5
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.螺内酯可减少 1 型糖尿病伴微量白蛋白尿患者的尿白蛋白排泄:一项随机安慰剂对照交叉研究。
Diabet Med. 2012 Aug;29(8):e184-90. doi: 10.1111/j.1464-5491.2012.03585.x.
6
Chronic kidney disease, dyslipidemia, and atherosclerosis.慢性肾脏病、血脂异常与动脉粥样硬化。
J Atheroscler Thromb. 2012;19(4):299-315. doi: 10.5551/jat.10454. Epub 2011 Dec 14.
7
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.醛固酮受体拮抗剂治疗心肌梗死后心力衰竭患者肾功能变化的决定因素及其后果:来自依普利酮治疗心肌梗死后心力衰竭疗效和生存研究的观察。
Circulation. 2012 Jan 17;125(2):271-9. doi: 10.1161/CIRCULATIONAHA.111.028282. Epub 2011 Nov 29.
8
Association of plasma renin activity and aldosterone-renin ratio with prevalence of chronic kidney disease: the Kaiser Permanente Southern California cohort.血浆肾素活性和醛固酮-肾素比值与慢性肾脏病患病率的关系:凯撒永久南加州队列研究。
J Hypertens. 2011 Nov;29(11):2226-35. doi: 10.1097/HJH.0b013e32834bbc8a.
9
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.醛固酮阻断治疗在慢性肾脏病相关的难治性高血压中的长期作用。
J Hum Hypertens. 2012 Aug;26(8):502-6. doi: 10.1038/jhh.2011.60. Epub 2011 Jun 16.
10
Renal function and target organ damage in hypertension.高血压中的肾功能和靶器官损害。
Eur Heart J. 2011 Jul;32(13):1599-604. doi: 10.1093/eurheartj/ehr003. Epub 2011 Mar 28.